SEC Form 4 · accession 0001179110-17-015284

Care.com Inc · CRCM

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Michael Echenberg

Officer — Chief Financial Officer

Period of report

Dec 9, 2017

Accepted (ET)

Dec 12, 2017 · 9:11 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001412270

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock, $0.001 par value^F1	Dec 9, 2017	M	7,825	—	A	18,419	D
Common Stock, $0.001 par value^F1	Dec 9, 2017	M	2,332	—	A	20,751	D
Common Stock, $0.001 par value^F1	Dec 9, 2017	M	544	—	A	21,295	D
Common Stock, $0.001 par value^F1	Dec 9, 2017	M	1,285	—	A	22,580	D
Common Stock, $0.001 par value	Dec 11, 2017	M	1,000	$6.70	A	23,580	D
Common Stock, $0.001 par value^F3	Dec 11, 2017	S	1,500	$19.0575	D	22,080	D
Common Stock, $0.001 par value^F9	Dec 12, 2017	S	4,372	$17.7743	D	17,708	D
Common Stock, $0.001 par value^F9	Dec 12, 2017	S	1,303	$17.7743	D	16,405	D
Common Stock, $0.001 par value^F9	Dec 12, 2017	S	304	$17.7751	D	16,101	D
Common Stock, $0.001 par value^F9	Dec 12, 2017	S	718	$17.7746	D	15,383	D

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Restricted Stock Units^F1,F4	—	Dec 9, 2017	M	7,825	D	—	—	Common Stock	7,825	46,950	D
Restricted Stock Units^F1,F5	—	Dec 9, 2017	M	2,332	D	—	—	Common Stock	2,332	20,987	D
Restricted Stock Units^F1,F6	—	Dec 9, 2017	M	544	D	—	—	Common Stock	544	4,898	D
Restricted Stock Units^F1,F7	—	Dec 9, 2017	M	1,285	D	—	—	Common Stock	1,285	16,697	D
Stock Option (Right to Buy)^F8	$6.70	Dec 11, 2017	M	1,000	D	—	Mar 10, 2026	Common Stock	1,000	80,780	D

Explanation of responses

F1Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
F2The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on September 13, 2017.
F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.88 to $19.30, inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3) to this Form 4.
F4The restricted stock units will vest as to 25% of the original number of restricted stock units on June 9, 2016 and as to an additional 6.25% of the original number of restricted stock units at the end of each successive three month period from June 9, 2016 until June 9, 2019. The restricted stock units have no expiration date.
F5The restricted stock units will vest as to 6.25% of the original restricted stock units at the end of each successive three month period from March 9, 2016 until March 9, 2020. The restricted stock units have no expiration date.
F6The restricted stock units will vest as to 25% of the original grant on March 9, 2017. The balance of the grant will vest in twelve equal quarterly installments beginning on June 9, 2017. The restricted stock units have no expiration date.
F7The restricted stock units will vest in sixteen equal installments beginning on June 9, 2017. The restricted stock units have no expiration date.
F8The option will vest as to 6.25% of the original number of securities acquired at the end of each successive three month period from March 9, 2016 until March 9, 2020.
F9These shares were sold to cover tax withholding obligations created by the vesting of Reporting Person's restricted stock units.